Your browser doesn't support javascript.
loading
PPARγ (Peroxisome Proliferator-Activated Receptor γ) Deacetylation Suppresses Aging-Associated Atherosclerosis and Hypercholesterolemia.
Zahr, Tarik; Liu, Longhua; Chan, Michelle; Zhou, Qiuzhong; Cai, Bishuang; He, Ying; Aaron, Nicole; Accili, Domenico; Sun, Lei; Qiang, Li.
Afiliação
  • Zahr T; Naomi Berrie Diabetes Center (T.Z., L.L., M.C., Y.H., N.A., D.A., L.Q.), Columbia University, New York.
  • Liu L; Departments of Molecular Pharmacology and Therapeutics (T.Z., N.A.), Columbia University, New York.
  • Chan M; Naomi Berrie Diabetes Center (T.Z., L.L., M.C., Y.H., N.A., D.A., L.Q.), Columbia University, New York.
  • Zhou Q; Pathology and Cell Biology (L.L., Y.H., L.Q.), Columbia University, New York.
  • Cai B; Naomi Berrie Diabetes Center (T.Z., L.L., M.C., Y.H., N.A., D.A., L.Q.), Columbia University, New York.
  • He Y; Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, Singapore (Q.Z., L.S.).
  • Aaron N; Division of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York (B.C.).
  • Accili D; Naomi Berrie Diabetes Center (T.Z., L.L., M.C., Y.H., N.A., D.A., L.Q.), Columbia University, New York.
  • Sun L; Pathology and Cell Biology (L.L., Y.H., L.Q.), Columbia University, New York.
  • Qiang L; Naomi Berrie Diabetes Center (T.Z., L.L., M.C., Y.H., N.A., D.A., L.Q.), Columbia University, New York.
Arterioscler Thromb Vasc Biol ; 43(1): 30-44, 2023 01.
Article em En | MEDLINE | ID: mdl-36453279
ABSTRACT

BACKGROUND:

Atherosclerosis is a medical urgency manifesting at the onset of hypercholesterolemia and is associated with aging. Activation of PPARγ (peroxisome proliferator-activated receptor γ) counteracts metabolic dysfunction influenced by aging, and its deacetylation displays an atheroprotective property. Despite the marked increase of PPARγ acetylation during aging, it is unknown whether PPARγ acetylation is a pathogenic contributor to aging-associated atherosclerosis.

METHODS:

Mice with constitutive deacetylation-mimetic PPARγ mutations on lysine residues K268 and K293 (2KR) in an LDL (low-density lipoprotein)-receptor knockout (Ldlr-/-) background (2KRLdlr-/-) were aged for 18 months on a standard laboratory diet to examine the cardiometabolic phenotype, which was confirmed in Western-type diet-fed 2KRLdlr+/- mice. Whole-liver RNA-sequencing and in vitro studies in bone marrow-derived macrophages were conducted to decipher the mechanism.

RESULTS:

In contrast to severe atherosclerosis in WTLdlr-/- mice, aged 2KRLdlr-/- mice developed little to no plaque, which was underlain by a significantly improved plasma lipid profile, with particular reductions in circulating LDL. The protection from hypercholesterolemia was recapitulated in Western-type diet-fed 2KRLdlr+/- mice. Liver RNA-sequencing analysis revealed suppression of liver inflammation rather than changes in cholesterol metabolism. This anti-inflammatory effect of 2KR was attributed to polarized M2 activation of macrophages. Additionally, the upregulation of core circadian component Bmal1 (brain and muscle ARNT-like 1), perceived to be involved in anti-inflammatory immunity, was observed in the liver and bone marrow-derived macrophages.

CONCLUSIONS:

PPARγ deacetylation in mice prevents the development of aging-associated atherosclerosis and hypercholesterolemia, in association with the anti-inflammatory phenotype of 2KR macrophages.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aterosclerose / Placa Aterosclerótica / Hipercolesterolemia Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aterosclerose / Placa Aterosclerótica / Hipercolesterolemia Idioma: En Ano de publicação: 2023 Tipo de documento: Article